论文部分内容阅读
病毒性肝炎是我国传染病住院患者中最常见的一类疾病,但由于其收治医院包括传染病专科医院、综合医院和中医院等不同类型的医院,对其分型、诊断标准及治疗方案的尚存在较大的差别,因此有必要对多家不同医院住院的病毒性肝炎患者的信息进行综合分析。该文以17家三级甲等医院HIS数据库中41 180例病毒性肝炎住院患者为研究对象,分析其一般信息、亚型分布、病情预后、合并疾病、发病和节气的关系及治疗药物。研究发现患者中以18~59岁的中青年男性多见;入院方式以普通门诊为多;医保为最常见医疗支付方式;从预后角度看,急性肝炎好于慢性者,年轻患者好于年老者,女性好于男性;合并疾病中以肝硬化和肝脏恶性肿瘤为多见;发病高峰为夏至、小暑和大暑3个节气;关于治疗药物,化学药以还原型谷胱甘肽为最常见,中药以甘草酸二胺最常见,中西药联合治疗是最多见的治疗模式,联合用药模式中以甘草酸二胺联合还原型谷胱甘肽、胸腺肽和多烯磷脂酰胆碱为主。由于该文为回顾性描述分析,疗效和治疗方案的之间的相关性未做分析,因此仅供临床医生在治疗选择中作参考。
Viral hepatitis is one of the most common types of hospitalized patients with infectious diseases in our country. However, due to its different types of hospitals such as specialized infectious diseases hospitals, general hospitals and Chinese medicine hospitals, its classification, diagnostic criteria and treatment programs There is still a big difference. Therefore, it is necessary to comprehensively analyze the information of patients with viral hepatitis who are hospitalized in different hospitals. In this paper, 41 180 inpatients with viral hepatitis in HIS database of 17 tertiary hospitals were selected as the research object, and their general information, subtypes distribution, prognosis, combined disease, incidence and solar terms and therapeutic drugs were analyzed. The study found that patients in 18 to 59-year-old young men more common; admission to the general out-patient as much as health insurance as the most common medical payment; from a prognostic point of view, acute hepatitis is better than chronic, young patients are better than the elderly , Women are better than men; combined disease with liver cirrhosis and liver cancer are more common; peak incidence for the summer solstice, small heat and big summer three solar terms; on the treatment of drugs, chemical drugs to reduced glutathione is the most common, traditional Chinese medicine The most common glycyrrhetinic acid diamine, the combination of Chinese and Western medicine is the most common treatment model, combination mode with glycyrrhizic acid diamine combined with reduced glutathione, thymosin and polyene phosphatidylcholine based. Since the article is retrospectively described and analyzed, the correlation between efficacy and treatment regimen is not analyzed and is therefore only for the clinician’s reference to treatment options.